People with Parkinson's and Linked Clinical Trials

Find out more about our Linked Clinical Trials here.

Latest

Support a Cure this Christmas

If you would like to support The Cure Parkinson’s Trust this Christmas we have put together six simple, festive fundraisers that you might like to take part in to help raise awareness and funds for our pioneering Parkinson’s research.
Parkinson's Drug Trial Documentary Wins 'Best Science' Award

'The Parkinson’s Drug Trial: A Miracle Cure?' has won a Grierson Award for Best Science Documentary. The series aired in early 2019 and followed late CPT Co-founder Tom Isaacs and 8 other people through a pioneering drug delivery procedure...
World Cup Christmas Dinner

Guests are invited to join past and present England rugby players Mike Tindall, Jason Leonard and Lawrence Dallaglio for a three course Christmas dinner and interactive sports quiz in support of CPT, The Atlas Foundation and Dallaglio Rugby Works.
Guy Deacon's Solo Sahara Trip

On Sunday 10 November retired Colonel Guy Deacon set off from his former school in Dorset to travel to Sierra Leone in his VW campervan to raise awareness and funds for CPT. Diagnosed with Parkinson’s eight years ago, guy anticipates that his journey will be one of adventure but also challenges a new. Here, Guy shares his story...

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.
Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.
New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut.
Science news

Read the latest Parkinson's science and research news here.
Trials - Repurposed Drugs

Our international Linked Clinical Trials initiative (LCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.
Apply for Funding
The NAC Trial - the facts
Our story
Diabetes Drug Potential Disease-Modifying Therapy

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.
Alpha-synuclein and Parkinson's

Science news

Read the latest Parkinson's science and research news here. Read more

The Cure Collective

The Cure Collective is an opportunity to join like-minded individuals who are committed to help drive forward the quest to find a cure for Parkinson’s... Read more

Our Annual Review 2019

Our Annual Review 2019 - your online publication here... Read more